Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options.
New study using Canary PASS data shows African-American men with low-risk disease can delay radical treatment just like white men.
Fred Hutch lung cancer expert testifies as Washington state weighs flavored vaping ban.
A new study shows a sharp drop in melanoma rates in people under 30, but skin cancer rates are still going up in those over 40.
The $4M ‘Breakthrough’ award funds collaborative research aimed at destroying dormant disseminated tumor cells.
Flu shots remain your best bet for protection, but no guarantee against infection
New research points to low fat for a longer life, but some patients are bumping up fat to keep cancer away. Is that smart?
Finding could shed new light on causes of certain cancers, anemias
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk.
High-tech approach solves ‘real mystery’ in many cancers.
Guided by evolution, scientists create more potent antiviral that unexpectedly continues blocking dissimilar viruses.
Tumors that turn off androgen receptor may have turned on new drug target.
The #NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other.
Engineered immune cells get a helping hand in a new clinical trial for multiple myeloma patients.
Engineered T cells kept leukemia from returning in 12 high-risk patients.
Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.